comparemela.com

Latest Breaking News On - Gregory berk - Page 6 : comparemela.com

GT Biopharma Announces the Promotion of Dr. Gregory Berk to President of Research & Development and Chief Medical Officer

GT Biopharma Announces the Promotion of Dr. Gregory Berk to President of Research & Development and Chief Medical Officer
pressreleasepoint.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pressreleasepoint.com Daily Mail and Mail on Sunday newspapers.

Anthony-cataldo
Beverly-hills
Gregory-berk
Jeffrey-miller
Board-member-of-sideris-pharmaceuticals
Global-clinical-development-at-abraxis-bioscience
European-society-of-medical-oncology
University-of-minnesota-to-cytovance
Research-development
Nasdaq
Exchange-commission
Weill-medical-college-of-cornell-university

Celularity Inc. completed the acquisition of GX Acquisition Corp. in a reverse merger transaction.

Celularity Inc. completed the acquisition of GX Acquisition Corp. in a reverse merger transaction.
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Joshua-friedman
Xiaokui-zhang
John-sculley
Davidc-beers
Maya-florence
Kevin-cooper
Elizabeth-lewis
Yvan-claude-pierre
Megan-browdie
Michelle-gasaway
Michael-chitwood
Avia-dunn

GT Biopharma Reports First Quarter 2021 Results

GT Biopharma Reports First Quarter 2021 Results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Anthonyj-cataldo
Jeffreys-miller
Cytovance-biologics
Beverly-hills
Gregory-berk
Rajesh-shrotriya
Michael-breen
Exchange-commission
Development-expenses
Leadership-team
Company-board-of-directors

GT Biopharma Announces the Appointments of Gregory Berk, M.D. to Chief Medical Officer and Jeffrey S. Miller, M.D. to Consulting Chief Scientific Officer

Share this article Share this article BEVERLY HILLS, Calif., April 26, 2021 /PRNewswire/ GT Biopharma, Inc. (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company s proprietary natural killer (NK) cell engager, TriKE™ protein biologic technology platform, today announced the appointment of Gregory Berk, M.D., to the position of Chief Medical Officer. Dr. Berk has served as a Director on GT Biopharma s Board since November 2020, and resigns that post in conjunction with his appointment. The Company is also pleased to announce that Jeffrey S. Miller, M.D., who has supported GT Biopharma as the Company s Consulting Chief Medical Officer since August 2019, will become the Company s Consulting Chief Scientific Officer. Dr. Miller, with his colleagues at the University of Minnesota, is the inventor of the novel TriKE™ technology platform. Dr. Miller will continue his leadership role with respect to the design a

Julie-seidel
Jeff-miller
Gregory-berk
Susan-roush
Jeffreys-miller
Anthonyj-cataldo
David-castaneda
Beverly-hills
Prnewswire-gt-biopharma-inc
Board-member-of-sideris-pharmaceuticals
Global-clinical-development-at-abraxis-bioscience

vimarsana © 2020. All Rights Reserved.